Document is current
Any future updates will be listed below
-
Authors
Tu, Yutong
Cai, Xiaojia
Tao, Zhaofan
Zhang, Ruisen
Li, Xian
Chen, Beijing
Zhang, Hualin https://orcid.org/0009-0004-7540-2626
Hu, Xiaobei https://orcid.org/0000-0002-7765-1771
Ke, Jiayi
Chen, Xiaoya
Bai, Xinyan
Li, Jia https://orcid.org/0000-0003-3224-001X
Xu, Tianfeng https://orcid.org/0000-0001-8996-4065
Zhou, Yubo https://orcid.org/0000-0002-0694-3697
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82273951)
Guangdong High-level new R&D Institute
Guangdong High-level Innovative Research Institute
- License Information
-
More Information
Article History
Received: 27 September 2025
Revised: 2 February 2026
Accepted: 10 March 2026
First Online: 25 March 2026
Competing interests
: The authors declare no competing interests.
: All methods were performed in accordance with the relevant guidelines and regulations. All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC), Zhongshan Institute for Drug Discovery Animal Center (Zhongshan, China) (Approval No. 2024-01-LJ-01, 2025-02-LJ-01, 2025-02-LJ-01-01). This study did not involve human participants.
